ACTIONABILITY KNOWLEDGE REPOSITORY ACTIONABILITY CURATION INTERFACE
Update History
Condition: Hyperparathyroidism 2 - HPRT2
Gene/Gene Panel: CDC73
Context: Pediatric
Date
Status
Release
Outcomes-Interventions
Notes
2024/04/30
Released
1.0.0
P
Morbidity from CDC73-related non-parathyroid lesions (GroupB)
Evaluation and management by specialists, including imaging surveillance to guide surgery (GroupB) 8NC
Morbidity from parathyroid adenoma (GroupA)
Evaluation and management by specialists, including biochemical surveillance to guide imaging and parathyroidectomy (GroupA) 10CC
Morbidity from parathyroid carcinoma (GroupA)
Evaluation and management by specialists, including biochemical and imaging surveillance to guide surgery (GroupA) 7DC
Release of a new report for the pediatric context.
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
CDC73 ⇔ 0007767 HYPERPARATHYROIDISM 1; HRPT1
N/A - Insufficient evidence: expert review
No Assertion: scoring group absence
CDC73 ⇔ 0007768 HYPERPARATHYROIDISM 2 WITH JAW TUMORS; HRPT2
Strong Actionability
Moderate Actionability
CDC73 ⇔ 0012004 PARATHYROID CARCINOMA
Strong Actionability
No Assertion: scoring group absence
2024/01/04
In Preparation
N/A
We have begun assessment of the Pediatric context for this topic
¤ Powered by BCM's Genboree.